Elevated truncated oxidized phospholipids as a factor exacerbating ALI in the aging lungs

Area of Science:

• Biochemistry
• Aging Research
• Pulmonology

Background:

• Aging compromises redox homeostasis, leading to increased oxidative stress.
• Oxidative stress promotes the formation of truncated oxidized phospholipids (Tr-OxPLs) from cell membranes and phospholipids.
• Elevated Tr-OxPLs are implicated in various pathological processes.

Purpose of the Study:

• To investigate the role of elevated Tr-OxPLs in exacerbating inflammation and lung barrier dysfunction in an aging animal model.
• To determine the impact of Tr-OxPLs on endothelial cell (EC) barrier function under inflammatory conditions.
• To explore the therapeutic potential of modulating Tr-OxPL generation.

Main Methods:

• Mass spectrometry to quantify Tr-OxPL species in young and aged mice lungs.
• Intratracheal lipopolysaccharide (LPS) and TNF-α challenges in mice to induce lung injury.
• In vitro cell culture models using endothelial cells (ECs) exposed to cytokine mixtures (CM) and Tr-OxPLs.
• In vivo and in vitro experiments involving the inhibition or pharmacologic manipulation of platelet-activating factor acetylhydrolase 2 (PAFAH2).

Main Results:

• Aged mice exhibited higher basal levels of Tr-OxPLs and increased Tr-OxPL generation following LPS challenge compared to young mice.
• Tr-OxPLs augmented EC barrier dysfunction and hyperpermeability induced by CM.
• Intravenous administration of POVPC exacerbated TNF-α-induced lung injury in young mice.
• Inhibition of Tr-OxPL generation via PAFAH2 reduced EC dysfunction, while PAFAH2 inhibition worsened lung injury.

Conclusions:

• There is an age-dependent increase in Tr-OxPL production, both basally and upon inflammatory stimulation.
• Elevated Tr-OxPLs play a significant role in the severity of acute lung injury (ALI) and delayed resolution in aging lungs.
• Modulating Tr-OxPL generation represents a potential therapeutic strategy for age-related lung diseases.